| | | | | |
ORMP Oramed Pharmaceuticals Inc. | $4,8450 | -3,49 % | $209,23M | $240,94K | |
OSG Octave Specialty Group, Inc. | $4,5400 | +4,13 % | $209,03M | $923,96K | |
| $61,7400 | -0,63 % | $208,63M | $4,82K | |
| $5,9150 | -3,66 % | $208,50M | $309,95K | |
ANTA Antalpha Platform Holding Company Class A Ordinary Shares | $4,0200 | +8,36 % | $208,49M | $2,19K | |
CMRC Commerce.com, Inc. Series 1 Common Stock | $2,3650 | -1,87 % | $207,14M | $324,88K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,2300 | +2,38 % | $206,15M | $43,56K | |
AESP Aeon Acquisition I Corp. Class A Ordinary Shares | $9,9700 | -0,10 % | $206,11M | $874,00 | |
TVIV Texas Ventures Acquisition IV Corp Class A Ordinary Shares | $9,9100 | -0,10 % | $205,42M | $789,00 | |
NPV Nuveen Virginia Quality Municipal Income Fund | $10,3500 | -1,15 % | $205,21M | $112,43K | |
WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares | $10,2500 | -0,10 % | $204,71M | $683,00 | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,5900 | +0,78 % | $204,65M | $569,26K | |
| $7,2400 | +4,62 % | $204,50M | $129,25K | |
ANGI Angi Inc. Class A Common Stock | $4,6600 | +0,22 % | $204,40M | $631,50K | |
| $7,3200 | -1,88 % | $203,13M | $60,00K | |
